Myocardial Injury in Patients with Hip Fracture: A HIP ATTACK Randomized Trial Substudy.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2025;13(10):61 J Bone Joint Surg Am . 2024 Dec 18;106(24):2303-2312.What this means for my practice?
Clinicians should recognize that myocardial injury in hip fracture patients is common and portends a poor prognosis, but accelerated surgery can significantly reduce mortality and major cardiac events in this group. This supports a shift away from delaying surgery for additional cardiac evaluation. However, findings are from a post-hoc analysis and require confirmation in a dedicated trial.
Study Summary
One thousand three hundred ninety-two patients with hip fracture who had a baseline troponin measurement were included in this post-hoc analysis of the HIP ATTACK trial. Of these, 322 (23%) presented with myocardial injury, defined by an elevated troponin level. These patients were randomized to receive either accelerated surgery (n=163) or standard care (n=159). The primary outcome was 90-day all-cause mortality. Secondary outcomes included a composite of all-cause mortality, non-fatal myocardial infarction, stroke, and congestive heart failure. Outcomes were assessed at 90 days post-randomization. Overall, the results revealed that patients with troponin elevation had significantly lower 90-day mortality with accelerated surgery (10%) compared to standard care (23%), along with fewer major cardiovascular complications. These findings suggest that accelerated surgery may be beneficial for hip fracture patients presenting with myocardial injury.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!